Gizem Tez
Research Subjects
Research Interests
Gizem Tez has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Halit Kanca
Ankara Üniversitesi
3 shared publications Dogukan Ozen
Department of Biostatistics, Faculty of Veterinary Medicine, Ankara University, Ankara, Turkey
1 shared publicationEray Alcigir
Department of Pathology, Faculty of Veterinary Medicine, Ankara University, Ankara, Turkey
1 shared publicationHavva Alemdar
1 shared publicationKazim Bal
Department of Obstetrics and Gynaecology, Ankara University, Ankara, Turkey
1 shared publication- Semra Ergül
ANKARA UNIVERSITY, INSTITUTE OF HEALTH SCIENCES
1 shared publication
Latest Publications
- Open Access
- 22 December 2023
- Published by Harran Universitesi Veteriner Fakultesi Dergisi in Harran Üniversitesi Veteriner Fakültesi Dergisi
- Vol. 12 (2) , 146-151
Surgical Time for Laparoscopic Ovariectomy in Adult and Prepubertal Dogs
Two-portal laparoscopic ovariectomy (LOVE) was performed in adult (n=23) and prepubertal dogs (n=23) to compare surgical time and to evaluate the effect of age, body weight (BW), body condition score (BCS), ovarian pedicle fat score (OPFS) and intraoperative surgical complications on surgical time. Three classes of BCS were considered: BCS 1-2=lean; BCS 3=ideal; BCS 4-5=overweight. All surgeries were performed by the same surgeon. OPF was scored and was considered negative or positive. Intraoperative complications were recorded. Total surgical time was recorded as time from the first skin incision to placement of the last portal closure suture. The surgical procedure was divided into 7 different stages and the time for each stage was recorded. Data are reported as mean±SEM. Differences in the duration of defined surgical stages between groups were evaluated by age, BW, OPFS and intraoperative complications. One-way analysis of variance was used to evaluate the effect of BCS. No major complications were observed. Five and 4 minor complications were observed in adult and prepubertal dogs, respectively. Total surgical time was not different (p>0.05) between adult (20.63±0.60 min) and prepubertal (21.48±1.75 min) dogs. BCS, BW and OPF did not affect total surgical time (p>0.05). Intraoperative complications prolonged surgical times (25.20±2.33 min vs 20.04±0.93 min). Time from first skin incision to insertion of first trocar was shorter (p<0.05) in prepubertal dogs (2.38±0.12 min) compared to adult animals (2.71±0.10 min). The time needed for grasping of the right ovary was longer (p<0.05) in prepubertal dogs (3.02±0.31 vs 2.32±0.16 min) and in animals without OPF (2.94±0.24 vs 2.11±1.89 min). In conclusion, LOVE is safe in both adult and prepubertal dogs with similar surgical time and complication rates.
- 22 December 2023
- Published by Harran Universitesi Veteriner Fakultesi Dergisi in Harran Üniversitesi Veteriner Fakültesi Dergisi
- Vol. 12 (2) , 146-151
Open AccessSurgical Time for Laparoscopic Ovariectomy in Adult and Prepubertal Dogs
Two-portal laparoscopic ovariectomy (LOVE) was performed in adult (n=23) and prepubertal dogs (n=23) to compare surgical time and to evaluate the effect of age, body weight (BW), body condition score (BCS), ovarian pedicle fat score (OPFS) and intraoperative surgical complications on surgical time. Three classes of BCS were considered: BCS 1-2=lean; BCS 3=ideal; BCS 4-5=overweight. All surgeries were performed by the same surgeon. OPF was scored and was considered negative or positive. Intraoperative complications were recorded. Total surgical time was recorded as time from the first skin incision to placement of the last portal closure suture. The surgical procedure was divided into 7 different stages and the time for each stage was recorded. Data are reported as mean±SEM. Differences in the duration of defined surgical stages between groups were evaluated by age, BW, OPFS and intraoperative complications. One-way analysis of variance was used to evaluate the effect of BCS. No major complications were observed. Five and 4 minor complications were observed in adult and prepubertal dogs, respectively. Total surgical time was not different (p>0.05) between adult (20.63±0.60 min) and prepubertal (21.48±1.75 min) dogs. BCS, BW and OPF did not affect total surgical time (p>0.05). Intraoperative complications prolonged surgical times (25.20±2.33 min vs 20.04±0.93 min). Time from first skin incision to insertion of first trocar was shorter (p<0.05) in prepubertal dogs (2.38±0.12 min) compared to adult animals (2.71±0.10 min). The time needed for grasping of the right ovary was longer (p<0.05) in prepubertal dogs (3.02±0.31 vs 2.32±0.16 min) and in animals without OPF (2.94±0.24 vs 2.11±1.89 min). In conclusion, LOVE is safe in both adult and prepubertal dogs with similar surgical time and complication rates.
- Open Access
- 15 January 2019
- Published by Veteriner Hekimler Dernegi Dergisi in Veteriner Hekimler Derneği Dergisi
- Vol. 90 (1) , 55-65
Köpeklerde kontrasepsiyon I: Cerrahi sterilizasyonun risk ve yararlarının değerlendirilmesi
Bilinen yüzlerce yıllık tarihi ile köpeklerde elektif cerrahi sterilizasyon, veteriner pratikte en sık gerçekleştirilen cerrahi prosedürdür. Köpeklerde; geleneksel orta hattan ovariohisterektomi, lateral ovariohisterektomi, ovariektomi, prepubertal sterilizasyon, laparoskopik ovariohisterektomi/ovariektomi, kastrasyon ve vazektomi gibi çok sayıda cerrahi sterilizasyon tekniği tanımlanmıştır. Köpeklerde cerrahi sterilizasyonun yapılıp yapılmayacağı veya ne zaman yapılacağına dair kararlar oldukça karmaşık bir süreci gerektirir. Veteriner hekimlerin köpeklerde cerrahi sterilizasyonun risk ve faydalarının yanı sıra, hangi yaşta uygulanması gerektiğine dair görüşleri arasında ciddi farklılıklar bulunmaktadır. Sterilizasyon kararı alınırken bir köpeğin evcil hayvan olarak uygunluğu, yaşam ortamı, diğer köpekler ile interaksiyonu, iş köpeği olarak çalışma potansiyeli, köpek popülasyon dinamikleri gibi birçok faktör ile birlikte temelde köpeğin sağlık durumu ve sağlık beklentileri göz önünde bulundurulmalıdır. Bu derlemede, konu ile ilgili güncel literatür ışığında, köpeklerde cerrahi sterilizasyon kararı verilirken değerlendirilmesi gereken uzun dönem sağlık risk ve yararları ele alınmıştır. Sonuç olarak, köpeklerde elektif cerrahi sterilizasyon; kontrasepsiyon, yaşam süresinin uzaması, meme ya da üreme sistemine ilişkin patolojilerin engellenmesi ve davranış problemlerinin azaltılması gibi amaçlarla veteriner hekimler tarafından şiddetle tavsiye edilmelidir.
- 15 January 2019
- Published by Veteriner Hekimler Dernegi Dergisi in Veteriner Hekimler Derneği Dergisi
- Vol. 90 (1) , 55-65
Open AccessKöpeklerde kontrasepsiyon I: Cerrahi sterilizasyonun risk ve yararlarının değerlendirilmesi
Bilinen yüzlerce yıllık tarihi ile köpeklerde elektif cerrahi sterilizasyon, veteriner pratikte en sık gerçekleştirilen cerrahi prosedürdür. Köpeklerde; geleneksel orta hattan ovariohisterektomi, lateral ovariohisterektomi, ovariektomi, prepubertal sterilizasyon, laparoskopik ovariohisterektomi/ovariektomi, kastrasyon ve vazektomi gibi çok sayıda cerrahi sterilizasyon tekniği tanımlanmıştır. Köpeklerde cerrahi sterilizasyonun yapılıp yapılmayacağı veya ne zaman yapılacağına dair kararlar oldukça karmaşık bir süreci gerektirir. Veteriner hekimlerin köpeklerde cerrahi sterilizasyonun risk ve faydalarının yanı sıra, hangi yaşta uygulanması gerektiğine dair görüşleri arasında ciddi farklılıklar bulunmaktadır. Sterilizasyon kararı alınırken bir köpeğin evcil hayvan olarak uygunluğu, yaşam ortamı, diğer köpekler ile interaksiyonu, iş köpeği olarak çalışma potansiyeli, köpek popülasyon dinamikleri gibi birçok faktör ile birlikte temelde köpeğin sağlık durumu ve sağlık beklentileri göz önünde bulundurulmalıdır. Bu derlemede, konu ile ilgili güncel literatür ışığında, köpeklerde cerrahi sterilizasyon kararı verilirken değerlendirilmesi gereken uzun dönem sağlık risk ve yararları ele alınmıştır. Sonuç olarak, köpeklerde elektif cerrahi sterilizasyon; kontrasepsiyon, yaşam süresinin uzaması, meme ya da üreme sistemine ilişkin patolojilerin engellenmesi ve davranış problemlerinin azaltılması gibi amaçlarla veteriner hekimler tarafından şiddetle tavsiye edilmelidir.
- Open Access
- 17 August 2018
- Published by Wiley in Veterinary Medicine and Science
- Vol. 4 (4) , 364-372
Intratumoral recombinant human interferon alpha‐2a and vincristine combination therapy in canine transmissible venereal tumour
Canine transmissible venereal tumour (CTVT) is a naturally occurring contagious neoplasm of dogs located mainly on the external genitalia of both sexes. The course of vincristine chemotherapy, the most effective and practical therapy, is affected by the immune status of the host. The aim was to investigate recombinant human interferon alpha‐2a (rhIFNα‐2a) and vincristine for treatment ofCTVT. A total of 21 female dogs were included. In group I (n = 9), vincristine (0.025 mg/kg,IV) was administered weekly. In groupII(n = 6), dogs were injected intratumorally weekly with 1.5 millionIUrhIFNα‐2a. In groupIII(n = 6), rhIFNα‐2a and vincristine were combined. No tumour regression was observed after three injections of rhIFNα‐2a in groupIIand weekly vincristine was administered. The number of tumour infiltrating lymphocytes (TILs), mitotic figures and apoptotic cells were counted in subsequent incisional tumour biopsies. The Kaplan–Meier Method was used to analyse survival using complete tumour regression as the outcome and Breslow Test was used for comparison of survival curves. Differences inTILs, cell proliferation and apoptosis between groups were assessed by analysis of covariance. Complete regression was observed in all animals included. Mean duration of vincristine treatment for complete regression was shorter in groupII(3.50 weeks, 95%CI, 3.06–3.94,P < 0.05) and groupIII(3.17 weeks, 95%CI, 2.84–3.49,P < 0.01) compared to group I (5.11 weeks, 95%CI, 4.42–5.80). Vincristine and rhIFNα‐2a combination increasedTILs inCTVTbiopsies compared to vincristine treatment (P = 0.017) and vincristine treatment after rhIFNα‐2a (P = 0.049). Vincristine treatment after rhIFNα‐2a (GroupII;P < 0.001) and rhIFNα‐2a and vincristine combination (GroupIII;P < 0.001) decreased apoptosis. The results indicate that intratumoral rhIFNα‐2a treatment alone is not effective inCTVT. However, combination of rhIFNα‐2a and vincristine shortens the duration of treatment compared to vincristine therapy.
- 17 August 2018
- Published by Wiley in Veterinary Medicine and Science
- Vol. 4 (4) , 364-372
Open AccessIntratumoral recombinant human interferon alpha‐2a and vincristine combination therapy in canine transmissible venereal tumour
Canine transmissible venereal tumour (CTVT) is a naturally occurring contagious neoplasm of dogs located mainly on the external genitalia of both sexes. The course of vincristine chemotherapy, the most effective and practical therapy, is affected by the immune status of the host. The aim was to investigate recombinant human interferon alpha‐2a (rhIFNα‐2a) and vincristine for treatment ofCTVT. A total of 21 female dogs were included. In group I (n = 9), vincristine (0.025 mg/kg,IV) was administered weekly. In groupII(n = 6), dogs were injected intratumorally weekly with 1.5 millionIUrhIFNα‐2a. In groupIII(n = 6), rhIFNα‐2a and vincristine were combined. No tumour regression was observed after three injections of rhIFNα‐2a in groupIIand weekly vincristine was administered. The number of tumour infiltrating lymphocytes (TILs), mitotic figures and apoptotic cells were counted in subsequent incisional tumour biopsies. The Kaplan–Meier Method was used to analyse survival using complete tumour regression as the outcome and Breslow Test was used for comparison of survival curves. Differences inTILs, cell proliferation and apoptosis between groups were assessed by analysis of covariance. Complete regression was observed in all animals included. Mean duration of vincristine treatment for complete regression was shorter in groupII(3.50 weeks, 95%CI, 3.06–3.94,P < 0.05) and groupIII(3.17 weeks, 95%CI, 2.84–3.49,P < 0.01) compared to group I (5.11 weeks, 95%CI, 4.42–5.80). Vincristine and rhIFNα‐2a combination increasedTILs inCTVTbiopsies compared to vincristine treatment (P = 0.017) and vincristine treatment after rhIFNα‐2a (P = 0.049). Vincristine treatment after rhIFNα‐2a (GroupII;P < 0.001) and rhIFNα‐2a and vincristine combination (GroupIII;P < 0.001) decreased apoptosis. The results indicate that intratumoral rhIFNα‐2a treatment alone is not effective inCTVT. However, combination of rhIFNα‐2a and vincristine shortens the duration of treatment compared to vincristine therapy.